342 related articles for article (PubMed ID: 11285241)
1. SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs.
Sureau A; Gattoni R; Dooghe Y; Stévenin J; Soret J
EMBO J; 2001 Apr; 20(7):1785-96. PubMed ID: 11285241
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
Wang J; Manley JL
RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA.
Ropers D; Ayadi L; Gattoni R; Jacquenet S; Damier L; Branlant C; Stévenin J
J Biol Chem; 2004 Jul; 279(29):29963-73. PubMed ID: 15123677
[TBL] [Abstract][Full Text] [Related]
4. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
5. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
[TBL] [Abstract][Full Text] [Related]
6. Several mRNAs with variable 3' untranslated regions and different stability encode the human PR264/SC35 splicing factor.
Sureau A; Perbal B
Proc Natl Acad Sci U S A; 1994 Feb; 91(3):932-6. PubMed ID: 8302870
[TBL] [Abstract][Full Text] [Related]
7. Uterine expression of alternatively spliced mRNAs of mouse splicing factor SC35 during early pregnancy.
Nie GY; Li Y; Batten L; Griffiths B; Wang J; Findlay JK; Salamonsen LA
Mol Hum Reprod; 2000 Dec; 6(12):1131-9. PubMed ID: 11101696
[TBL] [Abstract][Full Text] [Related]
8. Characterization of multiple alternative RNAs resulting from antisense transcription of the PR264/SC35 splicing factor gene.
Sureau A; Soret J; Guyon C; Gaillard C; Dumon S; Keller M; Crisanti P; Perbal B
Nucleic Acids Res; 1997 Nov; 25(22):4513-22. PubMed ID: 9358160
[TBL] [Abstract][Full Text] [Related]
9. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.
Merdzhanova G; Edmond V; De Seranno S; Van den Broeck A; Corcos L; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Cell Death Differ; 2008 Dec; 15(12):1815-23. PubMed ID: 18806759
[TBL] [Abstract][Full Text] [Related]
10. Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation.
Guil S; Gattoni R; Carrascal M; Abián J; Stévenin J; Bach-Elias M
Mol Cell Biol; 2003 Apr; 23(8):2927-41. PubMed ID: 12665590
[TBL] [Abstract][Full Text] [Related]
11. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
Li X; Shambaugh ME; Rottman FM; Bokar JA
RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
[TBL] [Abstract][Full Text] [Related]
12. Antagonistic factors control the unproductive splicing of SC35 terminal intron.
Dreumont N; Hardy S; Behm-Ansmant I; Kister L; Branlant C; Stévenin J; Bourgeois CF
Nucleic Acids Res; 2010 Mar; 38(4):1353-66. PubMed ID: 19965769
[TBL] [Abstract][Full Text] [Related]
13. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions.
Liu HX; Chew SL; Cartegni L; Zhang MQ; Krainer AR
Mol Cell Biol; 2000 Feb; 20(3):1063-71. PubMed ID: 10629063
[TBL] [Abstract][Full Text] [Related]
14. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production.
Jacquenet S; Decimo D; Muriaux D; Darlix JL
Retrovirology; 2005 May; 2():33. PubMed ID: 15907217
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements.
Mayeda A; Screaton GR; Chandler SD; Fu XD; Krainer AR
Mol Cell Biol; 1999 Mar; 19(3):1853-63. PubMed ID: 10022872
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the alternative splicing of tau exon 10 by SC35 and Dyrk1A.
Qian W; Liang H; Shi J; Jin N; Grundke-Iqbal I; Iqbal K; Gong CX; Liu F
Nucleic Acids Res; 2011 Aug; 39(14):6161-71. PubMed ID: 21470964
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
18. SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA.
Loh TJ; Moon H; Cho S; Jung DW; Hong SE; Kim DH; Green MR; Zheng X; Zhou J; Shen H
Oncol Rep; 2014 Jan; 31(1):273-9. PubMed ID: 24173428
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus regulation of SR proteins.
McFarlane M; Graham SV
Biochem Soc Trans; 2010 Aug; 38(4):1116-21. PubMed ID: 20659014
[TBL] [Abstract][Full Text] [Related]
20. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities.
Tacke R; Manley JL
EMBO J; 1995 Jul; 14(14):3540-51. PubMed ID: 7543047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
